Allan Geliebter Dr - NY New York, New York City 10023

Allan Geliebter Dr entered the industry of Specialty Outpatient Clinics, Nec in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 621498, which describes it as a Specialty Outpatient Clinics, Nec. For further clarification, the SIC classifies this business under the code 8093 and described it as a Specialty Outpatient Clinics, Nec. The business provides service to the B2C market.

To acquire more information, please contact Dr Allan Geliebter by calling (212) 308-0470 during business hours. You can also write to the business’ Single Location at 69th St & West End Avenue, New York City, New York NY 10023. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Allan Geliebter Dr
Representative: Dr Allan Geliebter
Place of Business: 69th St & West End Avenue, New York City, NY 10023
Contact Number: (212) 308-0470
Type of Service: Specialty Outpatient Clinics, Nec
SIC Number: 8093
NAICS Number: 621498
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2008
Income/Year: $0 to $49.999
Laborers: 1 to 4
Share This Company:

Allan Geliebter Dr is a company operating from New York, New York providing professional Specialty Outpatient Clinics, Nec and relevant B2C variables. It was founded in 2008 and registered with the SIC code 8093 as Specialty Outpatient Clinics, Nec, and with the NAICS code 621498 as Specialty Outpatient Clinics, Nec.

With a current employee count of 1 to 4, Allan Geliebter Dr has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Dr Allan Geliebter at (212) 308-0470 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 69th St & West End Avenue in New York City, New York 10023 and can be engaged online through the company website at , the company Twitter , and Facebook page .